9-98306298-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_005458.8(GABBR2):c.2052C>T(p.Pro684Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,613,292 control chromosomes in the GnomAD database, including 22,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.17   (  2178   hom.,  cov: 33) 
 Exomes 𝑓:  0.16   (  20317   hom.  ) 
Consequence
 GABBR2
NM_005458.8 synonymous
NM_005458.8 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -2.14  
Publications
16 publications found 
Genes affected
 GABBR2  (HGNC:4507):  (gamma-aminobutyric acid type B receptor subunit 2) The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own. Allelic variants of this gene have been associated with nicotine dependence.[provided by RefSeq, Jan 2010] 
GABBR2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 59Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - neurodevelopmental disorder with poor language and loss of hand skillsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 9-98306298-G-A is Benign according to our data. Variant chr9-98306298-G-A is described in ClinVar as Benign. ClinVar VariationId is 1167956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-2.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.2  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GABBR2 | NM_005458.8  | c.2052C>T | p.Pro684Pro | synonymous_variant | Exon 15 of 19 | ENST00000259455.4 | NP_005449.5 | |
| GABBR2 | XM_017015331.3  | c.1758C>T | p.Pro586Pro | synonymous_variant | Exon 14 of 18 | XP_016870820.1 | ||
| GABBR2 | XM_005252316.6  | c.1278C>T | p.Pro426Pro | synonymous_variant | Exon 13 of 17 | XP_005252373.1 | ||
| GABBR2 | XM_017015332.3  | c.1278C>T | p.Pro426Pro | synonymous_variant | Exon 12 of 16 | XP_016870821.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.166  AC: 25174AN: 152084Hom.:  2181  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
25174
AN: 
152084
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.170  AC: 42575AN: 251022 AF XY:  0.172   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
42575
AN: 
251022
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.164  AC: 240257AN: 1461090Hom.:  20317  Cov.: 33 AF XY:  0.166  AC XY: 120679AN XY: 726900 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
240257
AN: 
1461090
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
120679
AN XY: 
726900
show subpopulations 
African (AFR) 
 AF: 
AC: 
5675
AN: 
33464
American (AMR) 
 AF: 
AC: 
8617
AN: 
44684
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3398
AN: 
26128
East Asian (EAS) 
 AF: 
AC: 
6920
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
18289
AN: 
86218
European-Finnish (FIN) 
 AF: 
AC: 
7132
AN: 
53412
Middle Eastern (MID) 
 AF: 
AC: 
1538
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
178396
AN: 
1111350
Other (OTH) 
 AF: 
AC: 
10292
AN: 
60372
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.477 
Heterozygous variant carriers
 0 
 10694 
 21387 
 32081 
 42774 
 53468 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 6528 
 13056 
 19584 
 26112 
 32640 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.165  AC: 25177AN: 152202Hom.:  2178  Cov.: 33 AF XY:  0.165  AC XY: 12267AN XY: 74418 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
25177
AN: 
152202
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
12267
AN XY: 
74418
show subpopulations 
African (AFR) 
 AF: 
AC: 
7108
AN: 
41528
American (AMR) 
 AF: 
AC: 
2923
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
454
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
896
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
1017
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
1413
AN: 
10594
Middle Eastern (MID) 
 AF: 
AC: 
64
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
10738
AN: 
68006
Other (OTH) 
 AF: 
AC: 
393
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1112 
 2224 
 3335 
 4447 
 5559 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 280 
 560 
 840 
 1120 
 1400 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
588
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:5 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Neurodevelopmental disorder with poor language and loss of hand skills    Benign:1 
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epileptic encephalopathy    Benign:1 
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 59    Benign:1 
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.